300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Travel
Local
Platforms
InsurTech
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Renewable Energy
Facebook
Software
Blockchain
Theatre
Beauty
Medical
Fashion
Infrastructure
Web3
Recruiting
Social
Celebrity
Food and Beverage
Life Science
Cannabis
Publishing
Wine and Spirits
LGBT
Mobile Apps
Climate
Real Estate
Sporting Goods
Finance
Music
Art
Social Media
Manufacturing
Franchise
FinTech
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Enterprise
Transportation
Biotech
Community
Sustainability
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Angola
Bahamas
Bahrain
Europe
Jersey
Estonia
Bolivia
Cyprus
Belize
Algeria
Belarus
Finland
Italy
Qatar
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Katalyst Securities, VC Fund

Katalyst Securities

VC Fund

Katalyst Securities is an independent brokerage firm specializing in private equity investments. The firm provides financial services to a diverse client base of corporations, investment funds, and high net worth individuals. It buys and sells securities such as stocks, bonds, mutual funds, and other investment products.

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries Katalyst Securities invests in

FitnessMedicalGeneticsHealth CareLife Science

Stages Katalyst Securities invests in

Series BFunding Round

Countries Katalyst Securities invests in

United States

Investment Focus

Industry

  • Fitness 1 (50%)
  • Medical 1 (50%)
  • Genetics 1 (50%)
  • Health Care 1 (50%)
  • Life Science 1 (50%)
See all 9 industries →

Stage

  • Series B 1 (50%)
  • Funding Round 1 (50%)

Investments

CompanyDescriptionRoundLinks
Violet Defense Violet Defense
Violet Defense is on a journey to find new ways to protect people from harmful germs that have grown resistant to traditional forms of cleaning and disinfecting. After years of research, Mark discovered a unique way to combine a light source with a highly transmissive lens material to produce greater photonic energy. Because the lens can withstanddirect and immediate contact with the light source, we have the ability to miniaturize the technology deployment. Mark secured extensive worldwide patent protection for this breakthrough discovery.In 2012, Mark founded Violet Defense to research and develop new products using this patented technology that can help protect our world from germs. The first line, Surface Air Germ Elimination (S.A.G.E.) System hit the market in May 2017. The possibilities of where this technology goes from here are endless. $20M / Series B / Nov 02, 2021
Exicure Exicure
Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease. $20M / Sep 27, 2017

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Travel
Local
Platforms
InsurTech
Retail
Oil and Gas
Payments
Film
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
eSports
Renewable Energy
Facebook
Software
Blockchain
Theatre
Beauty
Medical
Fashion
Infrastructure
Web3
Recruiting
Social
Celebrity
Food and Beverage
Life Science
Cannabis
Publishing
Wine and Spirits
LGBT
Mobile Apps
Climate
Real Estate
Sporting Goods
Finance
Music
Art
Social Media
Manufacturing
Franchise
FinTech
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Enterprise
Transportation
Biotech
Community
Sustainability
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Angola
Bahamas
Bahrain
Europe
Jersey
Estonia
Bolivia
Cyprus
Belize
Algeria
Belarus
Finland
Italy
Qatar
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Katalyst Securities invest in?

Katalyst Securities invests primarily in Fitness, Medical and Genetics startups, most often at Series B and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Katalyst Securities last invest?

The most recent investment recorded for Katalyst Securities closed in Nov 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Katalyst Securities Katalyst Securities Find emails